Bacteremia due to Serratia marcescens.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002056:Burns / Q000150:complications / Q000401:mortality; D002404:Catheterization / Q000009:adverse effects; D004756:Enterobacteriaceae Infections; D006801:Humans; D007564:Japan; D007612:Kanamycin / Q000627:therapeutic use; D008297:Male; D008826:Microbial Sensitivity Tests; D008887:Military Medicine; D018805:Sepsis / Q000209:etiology* / Q000401:mortality; D012706:Serratia marcescens; D014481:United States; D014744:Vietnam; D014946:Wound Infection
D000900:Anti-Bacterial Agents; D007612:Kanamycin